BridgeBio Pharma Inc (NASDAQ:BBIO)

31.94
Delayed Data
As of Dec 04
 +1.00 / +3.23%
Today’s Change
6.64
Today|||52-Week Range
36.36
+319.16%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Viking Global Investors Lp
Sale7/18/20231,500,000$35.00$52.5M-1.78%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale4/05/2023120,000$15.46$1.9M+105.67%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale5/03/2023120,000$14.18$1.7M+121.81%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale8/16/202350,698$29.80$1.5M+7.18%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale11/17/202351,352$29.10$1.5M+9.20%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale8/17/202351,552$28.59$1.5M+12.43%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale11/16/202350,697$28.86$1.5M+10.67%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale2/03/2023120,000$11.01$1.3M+194.11%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale3/03/2023120,000$10.96$1.3M+193.84%
Stephenson Brian C
Chief Financial Officer & Secretary
Sale5/03/202364,929$14.18$920.7K+121.81%
Page of 6